Table 6.
Overview of postoperative characteristics of relevant studies of open lung biopsy in patients with respiratory insufficiency.
| Author, year [reference] | Complicationβ (%) | Specific diagnosis (%) | Treatment alteration (%) | Change in management after open lung biopsy | |||
|---|---|---|---|---|---|---|---|
| Steroids added (%) | Steroid dose increased (%) | Steroids stopped (%) | Total of patients who received steroids after open lung biopsy; [patients on steroids + added − stopped] (%) |
||||
| Warner et al., 1988 [5] | 19 | 66 | 70 | n/a | n/a | n/a | n/a |
| Papazian et al., 1998 [15] | 19 | 75 | 92 | 17 | n/a | 3 | n/a |
| Flabouris and Myburgh, 1999 [7] | 17 | 46 | 75 | 54 | n/a | 4 | n/a |
| Chuang et al., 2003 [6] | 24 | 47 | 65 | n/a | n/a | n/a | n/a |
| Patel et al., 2004 [8] | 7 | 60 | 60 | 46 | 2 | 3 | n/a |
| Kao et al., 2006 [9] | 20 | 44 | 73 | n/a | n/a | n/a | 61 |
| Arabi et al., 2007 [4] | 0 | 100 | 71 | 43 | n/a | n/a | n/a |
| Baumann et al., 2008 [10] | 7 | 70 | 81 | 26 | 26 | n/a | n/a |
| Lim et al., 2007 [16] | 56 | 86 | 64 | 42 | n/a | n/a | n/a |
| Charbonney et al., 2009 [17] | 26 | 68 | 89 | 5 | 16 | 16 | 42 |
| Kao et al., 2015 [11] | 14∗ | 44 | 49 | 16 | n/a | n/a | n/a |
| Hughes and McGuire, 1997 [18] | 37∗∗ | 74 | 85 | 41 | 15 | 4 | 4 |
| Lachapelle and Morin, 1995 [19] | 19ψ | 68 | 59 | 16 | n/a | n/a | n/a |
| Guerin et al., 2015 [3] | 25∧ | 50 | n/a | n/a | n/a | n/a | n/a |
| Papazian et al., 2007 [14] | 11∧∧ | 87 | 78 | 28 | n/a | n/a | n/a |
| Bove et al., 1994 [20] | 12∧∗ | 100∧∗∧ | 55 | 45 | n/a | 4 | 4 |
| Canver and Mentzer Jr., 1994 [21] | 55φ | 100 | 67 | 22 | 27 | n/a | n/a |
| Soh et al., 2005 [22] | 41μ∗ | 53 | 44 | 19∧μ | n/a | n/a | n/a |
| Present study | 30 | 67 | 67 | 17 | n/a | 5 | 5 |
n/a: not available, data was not made available in the paper.
β: complications definition includes persistent air leak more than 7 days or bleeding requiring a blood transfusion.
∗: complications related to surgery included postoperative air leak, pneumothorax, subcutaneous emphysema, bleeding, and wound infection.
∗∗: persistent air leak through chest tube postoperatively, postoperative pneumothorax, postoperative hemorrhage (>500 mL blood loss in first 24 h), postoperative myocardial infarction, intraoperative desaturation (oxygen saturation, 90% or PaO2, 60 mmHg) and persistent air leak postoperatively, intraoperative hypotension (>20% reduction in blood pressure), and postoperative pneumothorax.
ψ: prolonged air leak (>4 days) and massive subcutaneous emphysema.
∧: air leaks (leaky chest tubes without pneumothorax, pneumothoraces requiring chest tubes, subcutaneous emphysema without pneumothorax, and bronchopleural fistula after chest tube removal) and bleeding.
∧∧: required blood transfusion during the 48 hr period following OLB, for a hemothorax, mechanical complication beginning during the 48 hr period following OLB pneumothoraces, and moderate air leaks from operative chest tubes for 24 hrs that did not require surgery.
∧∗: persistent air leak (longest air leak lasted 14 days), bronchopleural fistula, and patients requiring reintubation with prolonged mechanical ventilation.
∧∗∧: includes interstitial pneumonitis, interstitial fibrosis, Pneumocystis carinii, bronchiolitis obliterans, lung carcinoma, metastatic carcinoma, infectious and other pathological diagnosis on lung biopsy.
φ: prolonged air leak requiring prolonged chest tube drainage but no surgical therapy.
μ∗: persistent air leak, bronchopleural fistula, empyema, and wound infection.
∧μ: added or dose changed.